Research Paper Volume 11, Issue 24 pp 12246—12269
Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma
Figure 6. Nomogram to predict the 0.5-, 1-, and 3-year survival probability of patients with GBM. (A) Prognostic nomogram to predict the survival of GBM patients based on the TCGA training set. Calibration curves of the nomogram for predicting survival at 0.5, 1, and 3 years in the TCGA training cohort (B–D), CGGA Batch-1 validation cohort (E–G), and CGGA Batch-2 validation cohort (H–J). The actual survival is plotted on the y-axis; the nomogram-predicted probability is plotted on the x-axis.